Key result
Antisolvent-precipitated ticagrelor prolongs tail bleeding time in rats ~4-fold versus unprocessed ticagrelor.
Why the study?
The study was conducted to augment the dissolution rate and antiplatelet activity of ticagrelor using controlled antisolvent precipitation.
Does controlled antisolvent precipitation of ticagrelor improve its dissolution rate and antiplatelet activity in rat models?
Does controlled antisolvent precipitation of ticagrelor improve its dissolution rate and antiplatelet activity in rat models?
Controlled antisolvent precipitation of ticagrelor significantly enhances its dissolution rate and in vivo antiplatelet activity in rat models.
Answers are grounded in this paper and cite their sources.
Enhanced antiplatelet activity in rat models supports formulation optimization; leaves open translation to human dosing or outcomes.
The goal of our study is to augment ticagrelor (TC)’s dissolution rate and antiplatelet activity via controlled antisolvent precipitation. A saturated ethanolic solution of TC was prepared in the absence and presence of poloxamer 188 or gelucire 44/14. Aerosil 200 was added before controlled precipitation using water or water-containing poloxamer (1% w/v). The resulting precipitate was dried and characterized using Fourier transform infrared spectroscopy (FTIR), differential scanning calorimetry (DSC), powder X-ray diffraction (PXRD), and in vitro dissolution. FTIR showed hydrogen bonding after the processing of TC. DSC and PXRD reflected partial amorphization. A significant enhancement (p < 0.05) in dissolution efficiency and TC amount released after five minutes was also shown. The most effective composition was F6, which comprised TC, poloxamer, and Aerosil (5:5:2.5), or F9, utilizing gelucire instead of poloxamer at a similar ratio. Assessment of tail bleeding time (min) exhibited a significant (p < 0.05) prolongation for rat groups treated with F6 (24.71 ± 5.46) and F9 (30.06 ± 1.63) compared with negative control (3.43 ± 0.46) and unprocessed TC (5.78 ± 2.18). These results suggest an enhancement of TC’s pharmacological activity probably due to enhanced bioavailability imparted with an enhanced dissolution rate. The study introduced controlled antisolvent precipitation as a simple tool for hastened TC’s dissolution.
No takes yet. Share an insight, caveat, or question.
El-Deeb et al. (2025) studied this question. Ticagrelor formulations prepared via controlled antisolvent precipitation (F6 and F9) vs. Unprocessed ticagrelor and negative control was evaluated on Tail bleeding time (min) (p=< 0.05). Ticagrelor formulations prepared via controlled antisolvent precipitation prolonged tail bleeding time in rats compared to unprocessed ticagrelor.
Synapse has enriched 10 related papers. Consider them for comparative context: